Where possibilities become realities.
TriMetis Life Sciences is a preclinical services company dedicated to helping you accelerate your research through access to specialized laboratories, quality biospecimen and research expertise.
OUR
TECHNOLOGY
OUR
SERVICES
Ai BIOSPECIMEN QUALITY
Proprietary imaging technology for evaluating Quality of Slides and FFPE Blocks - % tumor, % necrosis...
Ai DNA ISOLATION MAPPING
Proprietary imaging technology to assess region of interest (ROI) for selection of tumor content for NextGen Sequencing
DIGITAL IMAGE LIBRARIES
Leverage Digital Image Libraries for Ai Biomarker Development
ABOUT
US
TriMetis is a preclinical services company helping medical device, pharmaceutical, and biotech companies and academic institutions advance their research through specialty laboratory and consultation services.
In addition to our state-of-the-art GLP laboratory, TriMetis provides access to consulting services and human biospecimens to support your research.
Our consultants have extensive expertise in business strategy and development consulting, medical writing, protocol development, quality assurance and training, and project management services.
IN THE NEWS
November 13, 2017
UTHSC, Bioworks, TriMetis join efforts
University of Tennessee Health Science Center (UTHSC) will partner with the Memphis Bioworks Foundation and TriMetis Life Sciences to focus on commercializing bioscience and technology. Dr. Steve Bares, president and executive director of Memphis Bioworks, will serve as associate vice chancellor of research and entrepreneurship at UTHSC. Phil Cestaro, vice president of Life Sciences for Bioworks and president and CEO of TriMetris, will serve as associate vice chancellor of research and business development.
July 24, 2017
TriMetis A Case Study: Simplifying Complex Medical Sample Procurement for Tissue & Cancer Research
The market for procuring biospecimens for medical research is very complex and has a number of moving parts. In this case study by Streamline, they focus on how TriMetis’s Biospecimen division, which specializes in acquiring and delivering biospecimens for research, uses Streamline to aid researchers with more accurate and timely biospecimen delivery.
December 01, 2014
TriMetis' biospecimen's help define a key role for TIGIT in inhibiting chronic CD8 + T cell-dependent responses
TriMetis worked with Genentech on a prospective study to deliver Human Tumor and PBMC Samples Matched whole blood and fresh surgically resected tumor tissues. This study was successful in helping push Genentech's research forward
CONTACT
US
OUR
ADDRESSES
CORPORATE HEADQUARTERS:
20 South Dudley Street, Suite 806
Memphis, TN
38103
Email:
Tel: +1 (901) 866 1818